This article is more than 5 years old. Information may no longer be current.

FDA approves iDesign for hyperopia

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The FDA has approved a new indication for the Star S4 IR excimer laser system and iDesign system for LASIK patients with hyperopia, with or without astigmatism, according to a press release from Johnson & Johnson Vision.

iDesign, which creates an individualized treatment plan with a five-measurement capture sequence and high-definition sensor, can now treat myopia, mixed astigmatism or hyperopia, the release said.

The treatment can be used in a range of pupil sizes in patients aged 18 years and older. The five measurements captured during one sequence are wavefront aberrometry, wavefront refraction, corneal topography, keratometry and pupillometry.